The Estee Lauder Companies (EL)
(Delayed Data from NYSE)
$90.57 USD
-1.82 (-1.97%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $90.61 +0.04 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$90.57 USD
-1.82 (-1.97%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $90.61 +0.04 (0.04%) 7:58 PM ET
5-Strong Sell of 5 5
D Value A Growth C Momentum B VGM
Zacks News
NUS or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
Top Stock Reports for NVIDIA, Netflix & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Netflix (NFLX) and Starbucks (SBUX).
Company News for Nov 3, 2020
by Zacks Equity Research
Companies In The News Are: CLX, EL, NLSN, NCLH
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Wall Street Waits for U.S. Presidential Election
by Zacks Equity Research
Wall Street Waits for U.S. Presidential Election
Election Day: A Cure for Uncertainty?
by Mark Vickery
We start a new month in a more hopeful mood, after a rough October that lived up to its historical billing of the month most difficult to make money in equities.
Estee Lauder (EL) Beats Q1 Earnings Estimates, Hikes Dividend
by Zacks Equity Research
Estee Lauder's (EL) first-quarter fiscal 2021 sales and earnings fall year over year. Results reflect adverse impact of some retail store closures and lower traffic in reopened stores amid COVID-19.
Estee Lauder (EL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 60.00% and 2.15%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Things You Should Know About Clorox (CLX) Ahead of Q1 Earnings
by Zacks Equity Research
Clorox's (CLX) Q1 top line is likely to have gained from continued strong product demand and growth across segments. Higher costs and investments to meet demand are likely to have hurt margins.
Why Earnings Season Could Be Great for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Estee Lauder (EL) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Adverse impacts of coronavirus-induced temporary store closures and sluggishness in travel retail are likely to get reflected in Estee Lauder's (EL) first-quarter fiscal 2021 performance.
Altria (MO) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Altria's (MO) third-quarter 2020 results are likely to reflect gains from pricing and strength in oral tobacco products. However, cigarette volumes have been soft for a while.
Here's All You Should Note Before Kellogg's (K) Q3 Earnings
by Zacks Equity Research
Kellogg's (K) third-quarter results are likely to reflect strength in the retail business due to increased pandemic-led demand. However, soft away-from-home food demand and high costs are concerns.
Estee Lauder (EL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Estee Lauder (EL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
All You Should Know Before Church & Dwight (CHD) Q3 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2020 results are likely to reflect increased demand for household cleaning products amid the pandemic, though escalated costs are a concern.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
NUS vs. EL: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Zacks Market Edge Highlights: Amazon, Alibaba, Estee Lauder, RealReal and RH
by Zacks Equity Research
Zacks Market Edge Highlights: Amazon, Alibaba, Estee Lauder, RealReal and RH
Luxury Retail: Who's Winning During the Pandemic?
by Patrick Anderson
Innovation usually comes when a company is pushed to the brink. Will the luxury retailers come out of the coronavirus even stronger than before/
Coronavirus-Led Woes Hurt Coty (COTY), E-commerce Looks Solid
by Zacks Equity Research
Weakness in the Consumer Beauty segment along with currency headwinds are a concern for Coty (COTY). Nevertheless, its strategic partnerships and online business bode well.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
Top Analyst Reports for Facebook, Walmart & Morgan Stanley
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Walmart (WMT) and Morgan Stanley (MS).
Weekly Jobless Claims Increase Again
by Zacks Equity Research
Weekly Jobless Claims Increase Again.